Thr82

Site Information
DDDGEDFtPPILKEL SwissProt Entrez-Gene
Blast this site against: NCBI SwissProt PDB
Site Group ID: 11076065

In vivo Characterization
Methods used to characterize site in vivo:	mass spectrometry ( 1 , 2 )
Relevant cell line - cell type - tissue:	HepG2 (hepatic) ( 1 , 2 )

References
1	Possemato A (2009) CST Curation Set: 7313; Year: 2009; Biosample/Treatment: cell line, HepG2/-; Disease: hepatocellular carcinoma; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: (K/R)XX[ST] Curated Info
2	Possemato A (2009) CST Curation Set: 7312; Year: 2009; Biosample/Treatment: cell line, HepG2/-; Disease: hepatocellular carcinoma; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: (K/R)XX[ST] Curated Info